Keenan James Robbins, MBBS
- Part D claims, 2024
- 51
- Publications
- 16
- Industry payments
- $468
- State license
- 1
- Year NPI issued
- 2018
- Practice address
- MO
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Find Keenan Robbins' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Keenan James Robbins is a general surgeon in Missouri
Keenan Robbins practices in Missouri.
Keenan Robbins' NPI, 1487148441, was assigned on June 21, 2018. Keenan Robbins holds Missouri license 2018013212.
- NPI
- 1487148441NPI Registry (opens in a new tab)
- NPI enumeration date
- June 21, 2018
- NPI status
- Active
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); and Dmand AI Professional Profile Data
Dmand AI tracks the EHR system at Keenan James Robbins' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Keenan Robbins practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Keenan Robbins' practice | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Keenan James Robbins is one of 593 general surgeons in Missouri
Surgery is Keenan Robbins' primary specialty in the NPI Registry, under taxonomy code 208600000X. Keenan Robbins is licensed in Missouri.
Specialties and state licenses
- Surgery, MissouriPrimary
General surgeons near Keenan Robbins
Counts of general surgeons with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Keenan James Robbins' patients have a median age of 72
Across all payers, Dmand AI patient panel data puts Keenan Robbins' median patient age at 72, with 33% women.
Keenan Robbins' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women33%
- Men67%
Source: Dmand AI Patient Panel Data
Keenan James Robbins wrote 51 Medicare Part D claims in 2024
In 2024, Keenan Robbins wrote 51 Medicare Part D claims for 25 patients. 96% of them were for generic drugs. CMS names the drug for 47 of them, across 2 drugs with 11 or more claims each, at $213 in total drug cost. In 2018, CMS named 16 claims across 1 drug.
Keenan Robbins' Part D claims by kind of drug, 2024
- Generic49 claims96%
- Brand-name and other2 claims4%
Keenan Robbins' most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 162019: 47194%
Drugs named by CMS: 2 in 2019, 1 in 2018.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Keenan James Robbins has 16 publications on record
Dmand AI links 16 papers to Keenan Robbins, published from 2016 to 2025. 2021 was the busiest year, with 4. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Neoadjuvant Therapy. Keenan Robbins has published most often in Ann Surg Oncol. Keenan Robbins' most frequent co-authors are Ryan Courtney Fields, MD, Steven Martin Strasberg, MD and Michael Thomas Lecompte, MD.
Keenan Robbins' papers by year, 2016 to 2025
Topics Keenan Robbins writes about most
- Pancreatic Neoplasms
- Adenocarcinoma
- Neoadjuvant Therapy
- Pancreas
- Pancreatectomy
- Quality Improvement
- Tumor Microenvironment
- Venous Thromboembolism
Keenan Robbins' most frequent co-authors
- Ryan Courtney Fields, MD6 shared papers
- Steven Martin Strasberg, MD3 shared papers
- Michael Thomas Lecompte, MD2 shared papers
Recent publications by Keenan Robbins
See who Keenan Robbins researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Keenan Robbins works with, so you can find a warm path to the right general surgeons.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Keenan James Robbins received $468 in industry payments from 2018 to 2024
CMS Open Payments shows 7 general payments to Keenan Robbins from 7 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Sumitomo Pharma America, Inc. paid the most, $124.
General payments to Keenan Robbins by program year, 2018 to 2024
Companies that paid Keenan Robbins the most, 2018 to 2024
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Keenan James Robbins's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Keenan James Robbins
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Keenan James Robbins' NPI number?
Keenan James Robbins' NPI number is 1487148441. It was assigned on June 21, 2018, and it is active in the NPI Registry.
What does Keenan James Robbins specialize in?
Keenan James Robbins is a general surgeon in Missouri. The primary specialty in the NPI Registry is Surgery Physician (taxonomy code 208600000X).
What is Keenan James Robbins' medical license number?
Keenan Robbins holds Missouri license 2018013212.
What drugs does Keenan James Robbins prescribe most?
In 2019 Medicare Part D data, Keenan Robbins' most prescribed drugs by claims were Oxycodone HCl and Tramadol HCl.
Has Keenan James Robbins received payments from drug or device companies?
CMS Open Payments shows $468 in general payments to Keenan Robbins from 7 companies from 2018 to 2024. The largest total came from Sumitomo Pharma America, Inc.
How long has Keenan James Robbins been practicing?
Keenan Robbins' NPI was assigned in 2018.
Does Keenan James Robbins do research?
Dmand AI links 16 publications to Keenan Robbins, published from 2016 to 2025.
Who does Keenan James Robbins publish with?
Keenan Robbins' most frequent co-authors are Ryan Courtney Fields, MD (6 shared papers), Steven Martin Strasberg, MD (3 shared papers) and Michael Thomas Lecompte, MD (2 shared papers).
Selling to surgery practices?
See general surgeons in Missouri by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card